| 1 |
Jin Y, Guo Y, Yang J, Chu X, Huang X, Wang Q, Zeng Y, Su L, Lu S, Wang C, Yang J, Qu J, Yang Y, Wang B. A Novel "Inside-Out" Intraocular Nanomedicine Delivery Mode for Nanomaterials' Biological Effect Enhanced Choroidal Neovascularization Occlusion and Microenvironment Regulation. Adv Mater 2023;35:e2209690. [PMID: 36527723 DOI: 10.1002/adma.202209690] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Rafiei M, Chung JT, Chau Y. Roles of biomaterials in modulating the innate immune response in ocular therapy. Front Drug Deliv 2023;3. [DOI: 10.3389/fddev.2023.1077253] [Reference Citation Analysis]
|
| 3 |
Naik K, Du Toit LC, Ally N, Choonara YE. Advances in Polysaccharide- and Synthetic Polymer-Based Vitreous Substitutes. Pharmaceutics 2023;15. [PMID: 36839888 DOI: 10.3390/pharmaceutics15020566] [Reference Citation Analysis]
|
| 4 |
Luo RH, Tram NK, Parekh AM, Puri R, Reilly MA, Swindle-Reilly KE. The Roles of Vitreous Biomechanics in Ocular Disease, Biomolecule Transport, and Pharmacokinetics. Curr Eye Res 2023;48:195-207. [PMID: 35179421 DOI: 10.1080/02713683.2022.2033271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Annuryanti F, Domínguez-Robles J, Anjani QK, Adrianto MF, Larrañeta E, Thakur RRS. Fabrication and Characterisation of 3D-Printed Triamcinolone Acetonide-Loaded Polycaprolactone-Based Ocular Implants. Pharmaceutics 2023;15. [PMID: 36678872 DOI: 10.3390/pharmaceutics15010243] [Reference Citation Analysis]
|
| 6 |
Chien Y, Hsiao Y, Chou S, Lin T, Yarmishyn AA, Lai W, Lee M, Lin Y, Lin T, Hwang D, Lin T, Chiou S, Chen S, Yang Y. Nanoparticles-mediated CRISPR-Cas9 gene therapy in inherited retinal diseases: applications, challenges, and emerging opportunities. J Nanobiotechnol 2022;20:511. [DOI: 10.1186/s12951-022-01717-x] [Reference Citation Analysis]
|
| 7 |
Bohley M, Dillinger AE, Tamm ER, Goepferich A. Targeted drug delivery to the retinal pigment epithelium: Untapped therapeutic potential for retinal diseases. Drug Discov Today 2022:S1359-6446(22)00215-X. [PMID: 35654389 DOI: 10.1016/j.drudis.2022.05.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Moreira Castro BF, Nunes da Silva C, Barbosa Cordeiro LP, Pereira de Freitas Cenachi S, Vasconcelos-santos DV, Machado RR, Dias Heneine LG, Silva LM, Silva-cunha A, Fialho SL. Low-dose melittin is safe for intravitreal administration and ameliorates inflammation in an experimental model of uveitis. Current Research in Pharmacology and Drug Discovery 2022. [DOI: 10.1016/j.crphar.2022.100107] [Reference Citation Analysis]
|
| 9 |
Sadeghi A, Ruponen M, Puranen J, Cao S, Ridolfo R, Tavakoli S, Toropainen E, Lajunen T, Ranta V, van Hest J, Urtti A. Imaging, quantitation and kinetic modelling of intravitreal nanomaterials. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121800] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 10 |
Cáceres-Vélez PR, Hui F, Hercus J, Bui B, Jusuf PR. Restoring the oxidative balance in age-related diseases - An approach in glaucoma. Ageing Res Rev 2022;75:101572. [PMID: 35065274 DOI: 10.1016/j.arr.2022.101572] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 11 |
Mcguckin MB, Wang J, Ghanma R, Qin N, Palma SD, Donnelly RF, Paredes AJ. Nanocrystals as a master key to deliver hydrophobic drugs via multiple administration routes. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.03.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 12 |
Allyn MM, Luo RH, Hellwarth EB, Swindle-reilly KE. Considerations for Polymers Used in Ocular Drug Delivery. Front Med 2022;8:787644. [DOI: 10.3389/fmed.2021.787644] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 13 |
Sun YJ, Lin C, Wu M, Lee SH, Yang J, Kunchur CR, Mujica EM, Chiang B, Jung YS, Wang S, Mahajan VB. An intravitreal implant injection method for sustained drug delivery into mouse eyes. Cell Reports Methods 2021;1:100125. [DOI: 10.1016/j.crmeth.2021.100125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Sen M, Al-Amin M, Kicková E, Sadeghi A, Puranen J, Urtti A, Caliceti P, Salmaso S, Arango-Gonzalez B, Ueffing M. Retinal neuroprotection by controlled release of a VCP inhibitor from self-assembled nanoparticles. J Control Release 2021;339:307-20. [PMID: 34606936 DOI: 10.1016/j.jconrel.2021.09.039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Xie L, Yue W, Ibrahim K, Shen J. A Long-Acting Curcumin Nanoparticle/In Situ Hydrogel Composite for the Treatment of Uveal Melanoma. Pharmaceutics 2021;13:1335. [PMID: 34575410 DOI: 10.3390/pharmaceutics13091335] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 16 |
Khanani AM, Aziz AA, Weng CY, Lin WV, Vannavong J, Chhablani J, Danzig CJ, Kaiser PK. Port delivery system: a novel drug delivery platform to treat retinal diseases. Expert Opin Drug Deliv 2021;:1-6. [PMID: 34388956 DOI: 10.1080/17425247.2021.1968826] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 17 |
Ballios BG, Pierce EA, Huckfeldt RM. Gene editing technology: Towards precision medicine in inherited retinal diseases. Semin Ophthalmol 2021;36:176-84. [PMID: 33621144 DOI: 10.1080/08820538.2021.1887903] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 18 |
Hsu XL, Wu LC, Hsieh JY, Huang YY. Nanoparticle-Hydrogel Composite Drug Delivery System for Potential Ocular Applications. Polymers (Basel) 2021;13:642. [PMID: 33670014 DOI: 10.3390/polym13040642] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Godse R, Rathod M, De A, Shinde U. Intravitreal galactose conjugated polymeric nanoparticles of etoposide for retinoblastoma. Journal of Drug Delivery Science and Technology 2021;61:102259. [DOI: 10.1016/j.jddst.2020.102259] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 20 |
Lyu Q, Peng L, Hong X, Fan T, Li J, Cui Y, Zhang H, Zhao J. Smart nano-micro platforms for ophthalmological applications: The state-of-the-art and future perspectives. Biomaterials 2021;270:120682. [PMID: 33529961 DOI: 10.1016/j.biomaterials.2021.120682] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 21 |
Zhou X, Lv J, Li G, Qian T, Jiang H, Xu J, Cheng Y, Hong J. Rescue the retina after the ischemic injury by polymer-mediated intracellular superoxide dismutase delivery. Biomaterials 2021;268:120600. [PMID: 33360507 DOI: 10.1016/j.biomaterials.2020.120600] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 22 |
Huang X, Chau Y. Enhanced Delivery of siRNA to Retinal Ganglion Cells by Intravitreal Lipid Nanoparticles of Positive Charge. Mol Pharm 2021;18:377-85. [PMID: 33295773 DOI: 10.1021/acs.molpharmaceut.0c00992] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 23 |
Ryals RC, Patel S, Acosta C, McKinney M, Pennesi ME, Sahay G. The effects of PEGylation on LNP based mRNA delivery to the eye. PLoS One 2020;15:e0241006. [PMID: 33119640 DOI: 10.1371/journal.pone.0241006] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 15.7] [Reference Citation Analysis]
|
| 24 |
Supe S, Upadhya A, Singh K. Role of small interfering RNA (siRNA) in targeting ocular neovascularization: A review. Exp Eye Res. 2021;202:108329. [PMID: 33198953 DOI: 10.1016/j.exer.2020.108329] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 25 |
Ku CA, Pennesi ME. The new landscape of retinal gene therapy. Am J Med Genet C Semin Med Genet 2020;184:846-59. [PMID: 32888388 DOI: 10.1002/ajmg.c.31842] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 26 |
Zhang X, Li S, Tang Y, Guo Y, Gao S. Intractable Ocular Diseases and Treatment Progress. AAPS PharmSciTech 2020;21:236. [PMID: 32803351 DOI: 10.1208/s12249-020-01774-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 27 |
French LS, Mellough CB, Chen FK, Carvalho LS. A Review of Gene, Drug and Cell-Based Therapies for Usher Syndrome. Front Cell Neurosci 2020;14:183. [PMID: 32733204 DOI: 10.3389/fncel.2020.00183] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 28 |
Li Q, Weng J, Wong SN, Thomas Lee WY, Chow SF. Nanoparticulate Drug Delivery to the Retina. Mol Pharm 2021;18:506-21. [PMID: 32501716 DOI: 10.1021/acs.molpharmaceut.0c00224] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 29 |
Amato R, Giannaccini M, Dal Monte M, Cammalleri M, Pini A, Raffa V, Lulli M, Casini G. Association of the Somatostatin Analog Octreotide With Magnetic Nanoparticles for Intraocular Delivery: A Possible Approach for the Treatment of Diabetic Retinopathy. Front Bioeng Biotechnol 2020;8:144. [PMID: 32158755 DOI: 10.3389/fbioe.2020.00144] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 30 |
Qi T, Shi Y, Huang Y, Fu X, Qiu S, Sun Q, Lin G. The role of antibody delivery formation in cancer therapy. J Drug Target 2020;28:574-84. [PMID: 32037905 DOI: 10.1080/1061186X.2020.1728537] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 31 |
Luaces-Rodríguez A, Mondelo-García C, Zarra-Ferro I, González-Barcia M, Aguiar P, Fernández-Ferreiro A, Otero-Espinar FJ. Intravitreal anti-VEGF drug delivery systems for age-related macular degeneration. Int J Pharm 2020;573:118767. [PMID: 31669558 DOI: 10.1016/j.ijpharm.2019.118767] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 32 |
Huang X, Chau Y. Investigating impacts of surface charge on intraocular distribution of intravitreal lipid nanoparticles. Experimental Eye Research 2019;186:107711. [DOI: 10.1016/j.exer.2019.107711] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
